CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 221 SEK Market Closed
Market Cap: 5.3B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Investor Relations

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
Founder & Director
No Bio Available
Mr. Simon Ostergaard Ph.D.
CEO & President
No Bio Available
Mr. Magnus Blixt
Chief Financial Officer
No Bio Available
Ms. Adele Horn
Corporate Communications & Investor Relations Manager
No Bio Available
Mr. Peter Wilson
Vice President of Global Marketing
No Bio Available
Mr. Urban Strindlov
Vice President of Global Sales
No Bio Available
Nina Wallander
Vice President of Human Resources
No Bio Available

Contacts

Address
SKANE
Lund
Mobilvagen 12
Contacts
+46464601600.0
www.cellavision.com